The Effects of Rosmarinic Acid on the Liver Fibrosis Induced by Non-alcoholic Steatohepatitis in Male Mice

Background and Objectives: Non-Alcoholic Steatohepatitis (NASH) is a serious and increasing liver disease, which develops into cirrhosis, fibrosis, and hepatocellular carcinoma. Rosmarinic Acid (RA) is a powerful antioxidant and anti-inflammatory compound. Therefore, this study aimed to assess the r...

Full description

Bibliographic Details
Main Authors: Azam Moslehi, Tahereh Komeili-Movahed
Format: Article
Language:fas
Published: Qom University of Medical Sciences 2021-03-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
Subjects:
Online Access:http://journal.muq.ac.ir/article-1-3091-en.html
Description
Summary:Background and Objectives: Non-Alcoholic Steatohepatitis (NASH) is a serious and increasing liver disease, which develops into cirrhosis, fibrosis, and hepatocellular carcinoma. Rosmarinic Acid (RA) is a powerful antioxidant and anti-inflammatory compound. Therefore, this study aimed to assess the role of RA on a mouse model of NASH-induced liver fibrosis. Methods In this research, C57/BL6 mice were divided into 4 equal groups, as follows: the control, RA, NASH, and NASH+RA groups. In the third and fourth groups, NASH was induced by Methionine-Choline Deficient (MCD) diet for 8 weeks. In the RA and NASH+RA group, RA was intraperitoneally injected daily for 8 weeks in mice. After 8 weeks, the explored animals were sacrificed and the blood and liver samples were obtained. Then, Trichrome-Masson staining, serum, and molecular analyses were performed. Results After RA administration, the plasma levels of ALT and AST decreased. RA administration also reduced TGFβ and α-SMA genes expression. Finally, the histopathological evaluation revealed that RA administration decreased NASH-induced liver fibrosis. Conclusion It seems that RA administration improves NASH-induced liver fibrosis through the inhibition of the α-SMA/ TGF-β signaling pathway.
ISSN:1735-7799
2008-1375